- Molecular diagnostics refers to a field of medical testing that utilizes molecular biology techniques, such as PCR and NGS, to detect and monitor diseases, identify genetic predispositions, and guide targeted therapies, widely applied in healthcare, clinical laboratories, and research settings
- Market growth is driven by the rising prevalence of infectious diseases and chronic conditions, increasing demand for personalized medicine, and the growing adoption of advanced diagnostic technologies such as real-time PCR and next-generation sequencing
- The market is evolving with technological innovations in automated platforms, integration of AI and machine learning for result interpretation, and the development of portable, point-of-care diagnostic devices enhancing speed, accuracy, and accessibility
- For instance, companies such as Roche and Thermo Fisher Scientific are leveraging digital technologies and automation to deliver faster, more precise molecular diagnostic solutions tailored to clinical and laboratory needs
- The molecular diagnostics market is expected to witness sustained growth, supported by ongoing advancements in genomics, expanding healthcare infrastructure, and increased investment in early disease detection and precision medicine initiatives
